HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: CMA on NTP's triethanolamine (TEA) draft report

This article was originally published in The Rose Sheet

Executive Summary

CMA on NTP's triethanolamine (TEA) draft report: Chemical Manufacturers Association's "alkanolamines panel" will meet with the National Toxicology Program Feb. 28 to discuss the association's evaluation of NTP's draft technical report on the toxicology and carcinogenesis of TEA in rats and mice. According to NTP, a two-year study showed "some evidence" of carcinogenic activity in female mice dermally exposed to TEA "based on increased incidences of hepatocellular neoplasms" ("The Rose Sheet" May 15, p. 1). An independent consultant contracted by CMA found evidence of heliobacter hepaticus bacteria in frozen tissue samples obtained from NTP, thus, possibly confounding the NTP study results, according to CMA, since the bacteria has been shown to cause liver tumors. TEA is widely used in cosmetic formulations including emulsifiers and thickeners...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel